Americas (WHO region) vs Netherlands: Estimated antiretroviral therapy coverage among children
Americas (WHO region)
48
in 2025
Netherlands
76
in 2024
Americas (WHO region) rank
6th
Netherlands rank
8th
Estimated antiretroviral therapy coverage among children over time
- Americas (WHO region)
- Netherlands
How they compare
Netherlands currently reports 76 against 48 in Americas (WHO region), a difference of 28.
That makes Netherlands's figure about 1.6 times Americas (WHO region)'s.
Across all 25 years both countries report, Netherlands has been ahead every year.
Americas (WHO region) ranks 6th and Netherlands ranks 8th of 13 groups.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.5 | 89.3 | 77.8 | Netherlands |
| 2010s | 38 | 85.1 | 47.1 | Netherlands |
| 2020s | 44 | 81.4 | 37.4 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Americas (WHO region) or Netherlands?
- Netherlands, at 76 against 48 in Americas (WHO region) as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among children between Americas (WHO region) and Netherlands?
- 28, with Netherlands ahead.
- How many years of comparable data are there for Americas (WHO region) and Netherlands?
- 25 years are reported by both, from 2000 to 2024.
- How do Americas (WHO region) and Netherlands rank globally for estimated antiretroviral therapy coverage among children?
- Americas (WHO region) ranks 6th and Netherlands ranks 8th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.